Cocaine-induced vasculitis: Clinical and immunological spectrum

Current Rheumatology Reports

Volumn 14, Issue 6, 2012, Pages 532-538

  Espinoza, Luis R ^a   Alamino, Rodolfo Perez ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ANCA associated vasculitis; Clinical; Cocaine; Cocaine induced vasculitis; Diagnosis; Immunological; Levamisole; Midline granulomatous disease; Musculoskeletal; Spectrum; Treatment; Vasculitis

Indexed keywords

COCAINE; GRANULOCYTE ANTIBODY; LEVAMISOLE; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISONE;

AGRANULOCYTOSIS; ANGIONEUROTIC EDEMA; ARTHRALGIA; ARTHRITIS; ARTICLE; BLISTER; CLINICAL FEATURE; DIARRHEA; DRUG CONTAMINATION; DRUG ERUPTION; DRUG WITHDRAWAL; FEVER; FLUSHING; GRANULOMATOSIS; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; HYPONATREMIA; IMMUNOPATHOLOGY; LEUKOCYTOCLASTIC VASCULITIS; LEUKOENCEPHALOPATHY; LEUKOPENIA; LICHENOID ERUPTION; MALAISE; MYALGIA; NAUSEA AND VOMITING; NEUTROPENIA; PURPURA; PURPURIC RASH; PYODERMA GANGRENOSUM; SIDE EFFECT; SKIN NECROSIS; SKIN ULCER; STOMATITIS; THROMBOCYTOPENIA; URTICARIA; VASCULITIS; VEIN THROMBOSIS;

ADJUVANTS, IMMUNOLOGIC; AGRANULOCYTOSIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; COCAINE; COCAINE-RELATED DISORDERS; DRUG CONTAMINATION; HUMANS; LEVAMISOLE; VASCULITIS; VASOCONSTRICTOR AGENTS;

EID: 84869207486     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-012-0283-1     Document Type: Article

References (50)

1. Di Paolo T, Rouillard C, Morissette M, Levesque D, Bedard PJ. Endocrine and neurochemical actions of cocaine. Can J Physiol Pharmacol. 1989; 67: 1177-81. (Pubitemid 20002381)
2. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007; 369: 1047-53. (Pubitemid 46436128)
3. Seyer BA, Grist W, Muller S. Aggressive destructive midfacial lesion from cocaine abuse. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94: 465-70. (Pubitemid 41124751)
4. Stahelin L, Fialho SC, Neves FS, Junckes L, de Castro GR W, Pereira IA. Cocaine-induced midline destruction lesions with positive ANCA test mimicking Wegener's granulomatosis. Rev Bras Reumatol. 2012; 52: 434-7. Interesting case report and literature review about cocaine-induced midline lesions mimicking Wegener's granulomatosis.
5. Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum. 2004; 50: 2954-65. (Pubitemid 39209534)
6. Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol. 2008; 59: 483-7.
7. Hofbauer GF, Burg G, Nestle FO. Cocaine-related Stevens-Johnson syndrome. Dermatology. 2000; 201: 258-60.
8. Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine. Am J Med. 1989; 87: 664-8. (Pubitemid 20006506)
9. Wijnen PA, Bekers O, Drent M. Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers. Mol Diagn Ther. 2011; 15: 177-80.
10. Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009; 9: 177-96.
11. Nzerue CM, Hewan-Lowe K, Riley Jr LJ. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives. Am J Kidney Dis. 2000; 35: 783-95. (Pubitemid 30238188)
12. Sirvent AE, Enriquez R, Andrada E, Amoros F, Gallego JA, Gonzalez C, et al. Goodpasture's syndrome in a patient using cocaine - a case report and review of the literature. Clin Nephrol. 2007; 68: 182-5. (Pubitemid 47377343)
13. Fabbian F, Pala M, De Giorgi A, et al. Left kidney: an unusual site of cocaine-related renal infarction. A case report. Eur Rev Med Pharmacol Sci. 2012; 16: 30-3.
14. Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med J. 2007; 83: 389-94. (Pubitemid 46960825)
15. Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME. Cocaineassociated cerebral vasculitis. Semin Arthritis Rheum. 1995; 25: 172-83.
16. Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996; 46: 1291-6. (Pubitemid 26159289)
17. Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology. 1996; 46: 1741-3. (Pubitemid 26185805)
18. Su J, Li J, Li W, Altura BT, Altura BM. Cocaine induces apoptosis in cerebral vascular muscle cells: potential roles in strokes and brain damage. Eur J Pharmacol. 2003; 482: 61-6. (Pubitemid 37505927)
19. Han JS, Mandell DM, Poublanc J, Mardimae A, et al. BOLDMRI cerebrovascular reactivity findings in cocaine-induced cerebral vasculitis. Nat Clin Pract Neurol. 2008; 4: 628-32.
20. Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011; 20: 443-9.
21. Bianco F, Iacovelli E, Tinelli E, Lepre C, Pauri F. recurrent leukoencephalopathy in a cocaine abuser. Neurotoxicology. 2011; 32: 410-2.
22. Orriols R, Munoz X, Ferrer J, Huget P, Morell F. Cocaineinduced Churg-Strauss vasculitis. Eur Respir J. 1996; 9: 175-7.
23. Chen SC, Jang MY, Wang CS, Tsai KB, et al. Cocaine-related vasculitis causing scrotal gangrene. Ann Pharmacother. 2009; 43: 375-8.
24. Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep. 2009; 18: 1381-5. Initial report describing agranulocytosis associated with levamisolecontaminated cocaine use.
25. Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010; 133: 466-72.
26. Ejlertsen B, Mouridsen HT, Jensen MB, et al. Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer. Cancer. 2010; 116: 2081-9.
27. Oh J, Kemper MJ. Second-line options for refractory steroidsensitive and -resistant nephritic syndrome. Expert Rev Clin Pharmacol. 2010; 3: 527-37.
28. Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2011; 35: 176-8.
29. Macfarlane DG, Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. Br Med J. 1978; 18: 407-8. (Pubitemid 8318798)
30. Symoens J, Veys E, Mielans M, Pinals R. Adverse reactions to levamisole. Cancer Treat Rep. 1978; 62: 1721-30. (Pubitemid 9132928)
31. Williams GT, Johnson SAN, Dieppe PA, Huskisson EC. Neutropenia during treatment of rheumatoid arthritis with levamisole. Ann Rheum Dis. 1978; 37: 366-9. (Pubitemid 9017961)
32. Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010; 88: 408-11.
33. Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012; 50: 231-41.
34. Chai PR, Bastan W, Machan J, Hack JB, Babu KM. Levamisole exposure and hematologic indices in cocaine users. Acad Emerg Med. 2011; 18: 1141-7.
35. Poon SH, Baliog Jr CR, Sams RN, et al. Syndrome of cocainelevamisole- induced cutaneous vasculitis and immune-mediated leukopenia. Semin Arthritis Rheum. 2011; 41: 434-44. Complete description of clinical and hematological manifestations associated with levamisole-contaminated cocaine use.
36. Khan TA, Cuchacovich R, Espinoza LR, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Semin Arthritis Rheum. 2011; 41: 445-54. Comprehensive report with complete literature review of clinical and laboratory manifestations associated with levamisole-contaminated cocaine use.
37. Buchanan JA, Lavonas EJ. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole. Curr Opin Hematol. 2012; 19: 27-31.
38. Perkisas S, Vrelust I, Martin M, Gadisseur A, Schroyens W. A warning about agranulocytosis with the use of cocaine adulterated with levamisole. Acta Clin Belg. 2011; 66: 226-7.
39. Wolford A, McDonald TS, Eng H, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012; 40: 1067-75.
40. Ching JA, Smith Jr DJ. Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res. 2012; 33: 1-5.
41. Freyer CW, Peters M. Palpable purpura complicated by streptococcal toxic shock syndrome resulting in limb necrosis and amputation: a case of levamisole and cocaine coingestion. Pharmacotherapy. 2012; 32: 17-23.
42. Jacobs RS, Silva CY, Powers JG, et al. Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol. 2012; 34: 208-13.
43. Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM. Five consecutive cases of a cutaneous vasculopathy in users of levamisoleadulterated cocaine. J Clin Rheumatol. 2011; 17: 193-6.
44. Zwang NA, Van Wagner LB, Rose S. A case of levamisoleinduced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol. 2011; 17: 197-200.
45. Farmer RW, Malhotra PS, Mays MP, et al. Necrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole. J Burn Care Res. 2012; 33: e6-11.
46. Graf J, Lynch K, Yeh CL, et al. Purpura, cutaneous necrosis, and anti-neutrophil cytoplasmic antibodies associated with levamisoleadulterated cocaine. Arthritis Rheum. 2011; 63: 3998-4001. Very good description of the dermatological and autoimmune manifestations associated with the use of levamisole-contaminated cocaine.
47. McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011; 6: 2799-805.
48. Gulati S, Donato AA. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012; 23 [Epub ahead of print].
49. Friend K, Milone MC, Perrone J. Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients. Ann Emerg Med. 2011; Sep 27 [Epub ahead of print].
50. Lee KC, Ladizinski B, Federman DG. Complications associated with the use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012; 87: 581-6. Excellent review of the subject.